immatics biotechnologies GmbH Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
LMR PARTNERS LLP | 05/15/2025 | 1.34 M | $21.19 K | 3.88% | 1.30% |
ARISTEIA CAPITAL LLC | 05/16/2025 | 838.88 K | $14.93 K | 0.88% | 0.81% |
D. E. SHAW & CO., INC. | 05/15/2025 | 792.35 K | $12.52 K | 0.00% | 0.77% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 348.03 K | $5.50 K | 0.00% | 0.34% |
AEQUIM ALTERNATIVE INVESTMENTS LP | 05/13/2025 | 252.74 K | $3.99 K | 0.00% | 0.25% |
NANTAHALA CAPITAL MANAGEMENT, LLC | 05/15/2025 | 248.51 K | $27.96 K | 0.00% | 0.24% |
AFFINITY ASSET ADVISORS, LLC | 05/14/2025 | 187.20 K | $2.96 K | 0.00% | 0.18% |
SPHERA FUNDS MANAGEMENT LTD. | 05/15/2025 | 100.00 K | $1.58 K | 0.00% | 0.10% |
BOOTHBAY FUND MANAGEMENT, LLC | 05/15/2025 | 77.09 K | $347.69 K | 0.00% | 0.07% |
WOLVERINE ASSET MANAGEMENT LLC | 05/12/2025 | 64.38 K | $1.02 K | -0.37% | 0.06% |
WEISS ASSET MANAGEMENT LP | 05/15/2025 | 40.07 K | $633 | 0.00% | 0.04% |
UBS GROUP AG | 05/13/2025 | 2.70 K | $43 | 1,799.30% | 0.00% |
WALLEYE CAPITAL LLC | 05/14/2025 | 0 | $0 | -100.00% | 0.00% |
PRIVIUM FUND MANAGEMENT B.V. | 05/09/2025 | 0 | $0 | -100.00% | 0.00% |
immatics biotechnologies GmbH institutional Ownership - FAQ's
During the previous two years, 16 institutional investors and hedge funds held shares of immatics biotechnologies GmbH. The most heavily invested institutionals were:
LMR Partners LLP: 1.34 M
ARISTEIA CAPITAL LLC: 838,876
D. E. Shaw & Co., Inc.: 792,353
683 Capital Management, LLC: 348,032
Aequim Alternative Investments LP: 252,741
Nantahala Capital Management, LLC: 248,506
4.17% of immatics biotechnologies GmbH stock is owned by institutional investors.
Institutional investors have bought a total of 4.48 M shares in the last 24 months. This purchase volume represents approximately $44.79 K in transactions.